Day 4: Zepbound (Tirzepatide weight loss indication) FDA Approved: November 2023 for weight management Weight Loss: Up to 22.5% in clinical trials Similar to Mounjaro, but marketed specifically for weight management. Tirzepatide vs Retatrutide What You Need to Know The next generation of metabolic therapy is here and the science is exciting. Here's a quick breakdown of both: Tirzepatide ( Novo Nordisk secures FDA approval for Wegovy to treat MASH Ancient Nutrition Advanced Hydrolyzed Collagen Peptides Powder Protein Lean with Probiotics and Vitamin C, Cinnamon, for Women & Men, Supports Healthy Does Stopping Ozempic Cause Rebound Weight Gain and Health Problems? Scientific American Weight Loss & Vitality LinkedIn